clofibric acid has been researched along with Cardiomyopathies in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pruimboom-Brees, I | 1 |
| Haghpassand, M | 1 |
| Royer, L | 1 |
| Brees, D | 1 |
| Aldinger, C | 1 |
| Reagan, W | 1 |
| Singh, J | 1 |
| Kerlin, R | 1 |
| Kane, C | 1 |
| Bagley, S | 1 |
| Hayward, C | 1 |
| Loy, J | 1 |
| O'Brien, P | 1 |
| Francone, OL | 1 |
1 other study available for clofibric acid and Cardiomyopathies
| Article | Year |
|---|---|
A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis.
Topics: Acyl-CoA Oxidase; Animals; Anticholesteremic Agents; Biomarkers; Cardiomyopathies; Clofibric Acid; F | 2006 |